Go Deep
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,911 | -0.3 | 0.28 | 0.00 | 38.84 |
| Oct 2026 | 22,884 | -0.3 | 0.28 | 0.00 | 39.78 |
| Oct 2026 | 21,105 | -0.3 | 0.28 | 0.00 | 39.09 |
| Oct 2026 | 21,112 | -0.3 | 0.28 | 0.00 | 38.87 |
| Oct 2026 | 20,897 | -0.3 | 0.33 | 0.00 | 46.14 |
| Oct 2026 | 21,014 | -0.3 | 0.30 | 0.00 | 42.02 |
Pasithea Therapeutics Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -5,273,852.0 | -2,869,482.0 | -10,110,868.0 | -3,037,420.0 |
| EPS | -0.2 | -0.1 | — | -0.4 |
Pasithea Therapeutics Corp. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -20,427,683.0 | -13,904,584.0 | -15,961,658.0 | -13,936,452.0 | — |
| EPS | -2.9 | -12.7 | -13.0 | -11.0 | — |
Pasithea Therapeutics Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 60,240,070.0 | 16,064,719.0 | 26,116,858.0 | 45,180,089.0 | — |
| Total Liabilities | 5,020,832.0 | 1,282,043.0 | 2,718,406.0 | 2,681,841.0 | — |
| Total Equity | 55,219,238.0 | 14,782,676.0 | 23,398,452.0 | 42,498,248.0 | — |
Owes vs Owns
Pasithea Therapeutics Corp. owed $0.04 for every $1 it owned in Jun 2026, down from $0.06 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.04× | 0.08× | 0.08× | 0.10× | 0.06× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Pasithea Therapeutics Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 91.6%Intangible assets 6.3%Other assets 2.2%
How it's funded — Dec 2025
Payables 1.9%Other liabilities 6.5%Shareholders' equity 91.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 55.2 | 6.9 | 16.3 | 33.1 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.1 | 0.2 | 0.6 |
| Intangible assets | 3.8 | 8.6 | 9.2 | 9.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.3 | 0.4 | 0.3 | 1.6 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.1 | 0.2 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.3 |
| Payables | 1.1 | 1.1 | 2.6 | 1.5 |
| Other liabilities | 3.9 | 0.2 | 0.1 | 0.7 |
| Shareholders' equity | 55.2 | 14.8 | 23.4 | 42.5 |
| Net tangible assets | 51.4 | 6.2 | 14.2 | 32.7 |
Pasithea Therapeutics Corp. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -15,211,490.0 | -13,923,438.0 | -13,425,411.0 | -13,691,158.0 | — |
| Investing Activities | 11,000.0 | 0.0 | 399,006.0 | -2,926,597.0 | — |
| Financing Activities | 63,518,800.0 | 4,517,634.0 | -3,726,416.0 | -3,206,244.0 | — |